Essential Steps to Achieving Quality and Compliance
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information19th February 2026
Summary: The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that medical device testing in the UK reached record levels in 2025, reflecting growing industry confidence and investment in advanced technologies. The surge is linked to increased activity in neurological devices and AI-enabled tools, with the MHRA supporting developers through regulatory advice, targeted guidance and accelerated assessment pathways. Highlighted initiatives include collaboration with innovators in AI for diagnostics and therapy support, and efforts to strengthen the UK’s position as a global hub for life sciences technology. This trend underscores the agency’s commitment to ensuring high-quality testing capacity, facilitating access to cutting-edge devices, and maintaining patient safety as innovation accelerates.